神戸大学附属図書館デジタルアーカイブ
入力補助
English
カテゴリ
学内刊行物
ランキング
アクセスランキング
ダウンロードランキング
https://hdl.handle.net/20.500.14094/0100488529
このアイテムのアクセス数:
269
件
(
2024-07-03
14:51 集計
)
閲覧可能ファイル
ファイル
フォーマット
サイズ
閲覧回数
説明
0100488529 (fulltext)
pdf
2.54 MB
287
メタデータ
ファイル出力
メタデータID
0100488529
アクセス権
open access
出版タイプ
Version of Record
タイトル
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan
著者
Ogawa, Wataru ; Hirota, Yushi ; Miyazaki, Shigeru ; Nakamura, Tadashi ; Ogawa, Yoshihiro ; Shimomura, Iichiro ; Yamauchi, Toshimasa ; Yokote, Koutaro ; on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO)
著者ID
A1358
研究者ID
1000040294219
KUID
https://kuid-rm-web.ofc.kobe-u.ac.jp/search/detail?systemId=38228987a3a438c8520e17560c007669
著者名
Ogawa, Wataru
小川, 渉
オガワ, ワタル
所属機関名
医学研究科
著者ID
A1420
研究者ID
1000080566018
KUID
https://kuid-rm-web.ofc.kobe-u.ac.jp/search/detail?systemId=8d8b694f29475700520e17560c007669
著者名
Hirota, Yushi
廣田, 勇士
ヒロタ, ユウシ
所属機関名
医学研究科
著者名
Miyazaki, Shigeru
著者名
Nakamura, Tadashi
著者名
Ogawa, Yoshihiro
著者名
Shimomura, Iichiro
著者名
Yamauchi, Toshimasa
著者名
Yokote, Koutaro
著者名
on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO)
収録物名
Endocrine Journal
巻(号)
71(3)
ページ
223-231
出版者
Japan Endocrine Society
日本内分泌学会
刊行日
2024
公開日
2024-04-04
抄録
To identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of “obesity disease.” Here we summarize the definition, criteria, and core concepts for the management of obesity disease based on JASSO’s latest guideline. JASSO defines obesity as excessive fat storage in adipose tissue associated with a BMI of ≥25 kg/m². The threshold BMI of obesity is low as compared to Western countries given that Japanese individuals tend to develop obesity-related health disorders at lower BMI. Obesity with a BMI of ≥35 kg/m² is referred to as “high-degree obesity” as treatment strategies vary based on the degree of obesity. Obesity is diagnosed as “obesity disease” if accompanied by any of the 11 specific obesity-related health disorders that weight reduction can prevent or alleviate, or if it meets the criteria for visceral fat obesity with a visceral fat area of ≥100 cm². The initial weight reduction goals for high-degree obesity disease range from 5% to 10% of their current body weight, depending on the associated health disorders. That for those with obesity disease who do not qualify as high-degree is 3% or more. If these initial goals are not achieved, intensifying dietary therapy or introducing drug therapy (or both) may be necessary. While surgical treatment is primarily indicated for high-degree obesity disease, it might be appropriate for cases of obesity disease with a BMI <35 kg/m², depending on the accompanying health disorders. Enhancing the quality of life for individuals with obesity or obesity disease necessitates a broader societal approach, emphasizing the resolution of related stigma.
キーワード
Obesity
Obesity disease
Management guideline
Visceral fat obesity
カテゴリ
医学研究科
学術雑誌論文
権利
© The Japan Endocrine Society
This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
詳細を表示
資源タイプ
journal article
言語
English (英語)
ISSN
0918-8959
OPACで所蔵を検索
CiNiiで学外所蔵を検索
eISSN
1348-4540
OPACで所蔵を検索
CiNiiで学外所蔵を検索
関連情報
DOI
https://doi.org/10.1507/endocrj.EJ23-0593
ホームへ戻る